πŸ“‹ Medical Procedure Code

Q0173

Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Other Descriptions:
Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to e
TRIMETHOBENZAMIDE HCL 250MG
Related codes:
Code: Q0170
HPromethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exce
Code: Q0171
CHLORPROMAZINE HCL 10MG ORAL
Code: Q0172
HChlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exc
Code: Q0174
Description: Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Category: Temporary codes (limited use and guidelines specific)
Code: Q0175
Description: Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Category: Temporary codes (limited use and guidelines specific)
Code: Q0176
HPerphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosa
Code: Q0177
Description: Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Category: Temporary codes (limited use and guidelines specific)
Code: Q0178
HHydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48
Code: Q0179
Ondansetron hcl 8 mg oral

Hospital Prices in Massachusetts

Detailed hospital-level pricing for procedure code Q0179 across Massachusetts. Compare prices from different hospitals to understand cost variations in your area.

πŸ—ΊοΈ Hospital Locations Map

πŸ’‘ Tip: Click on any marker to see hospital details. Colors indicate relative pricing - red shows higher prices, green shows lower prices.

πŸ“Š Hospital Prices in Massachusetts

State Average: $4

Hospital Address Code Price Last Updated
Mclean Hospital 115 Mill St, Belmont Q0173 $1 [source] 4 years ago
Spaulding Hospital Cambridge 1575 Cambridge St, Cambridge Q0173 $4 [source] 4 years ago
Newton Wellesley Hospital 2014 Washington St, Newton Lower Falls Q0173 $5 [source] 4 years ago
North Shore Medical Center Hospital 81 Highland Ave, Salem Q0173 $5 [source] 4 years ago
Brigham & Womens Hospital, Inc. 75 Francis St, Boston Q0173 $5 [source] 4 years ago
Brigham & Women Hospital 75 Francis St, Boston Q0173 $5 [source] 4 years ago
Spaulding Rehab Hospital Boston 300 1St Ave, Charlestown Q0173 $5 [source] 4 years ago
Spaulding Rehab Hospital Cape Cod 311 Service Rd, East Sandwich Q0173 $5 [source] 4 years ago
Brigham & Women Faulkner Hospital 1153 Centre St, Jamaica Plain Q0173 $5 [source] 4 years ago

ℹ️ About This Data

The prices shown are from hospital chargemaster files, which represent the list prices hospitals charge before insurance negotiations or discounts. Your actual cost may be different depending on your insurance coverage, deductibles, and negotiated rates. Always check with your insurance provider and hospital for accurate cost estimates.


ChargemasterDB by Joseph Paul Cohen
A database of US hospital prices based on data made available by the Centers for Medicare & Medicaid Services (CMS), HHS price transparancy rule 45 CFR Β§180.